Participant experiences in a breastmilk biomonitoring study: A qualitative assessment by Wu, Nerissa et al.
BioMed  Central
Page 1 of 9
(page number not for citation purposes)
Environmental Health
Open Access Research
Participant experiences in a breastmilk biomonitoring study: A 
qualitative assessment
Nerissa Wu*1, Michael D McClean1, Phil Brown2, Ann Aschengrau3 and 
Thomas F Webster1
Address: 1Department of Environmental Health, Boston University School of Public Health, 715 Albany Street, Boston, MA 02118, USA, 
2Department of Sociology, Brown University, Box 1916, Providence, RI 02912, USA and 3Department of Epidemiology, Boston University School 
of Public Health, 715 Albany Street, Boston, MA 02118, USA
Email: Nerissa Wu* - nerissa.wu@cdph.ca.gov; Michael D McClean - mmcclean@bu.edu; Phil Brown - Phil_Brown@brown.edu; 
Ann Aschengrau - aaschen@bu.edu; Thomas F Webster - twebster@bu.edu
* Corresponding author    
Abstract
Background: Biomonitoring studies can provide information about individual and population-
wide exposure. However they must be designed in a way that protects the rights and welfare of
participants. This descriptive qualitative study was conducted as a follow-up to a breastmilk
biomonitoring study. The primary objectives were to assess participants' experiences in the study,
including the report-back of individual body burden results, and to determine if participation in the
study negatively affected breastfeeding rates or duration.
Methods:  Participants of the Greater Boston PBDE Breastmilk Biomonitoring Study were
contacted and asked about their experiences in the study: the impact of study recruitment
materials on attitudes towards breastfeeding; if participants had wanted individual biomonitoring
results; if the protocol by which individual results were distributed met participants' needs; and the
impact of individual results on attitudes towards breastfeeding.
Results:  No participants reported reducing the duration of breastfeeding because of the
biomonitoring study, but some responses suggested that breastmilk biomonitoring studies have the
potential to raise anxieties about breastfeeding. Almost all participants wished to obtain individual
results. Although several reported some concern about individual body burden, none reported
reducing the duration of breastfeeding because of biomonitoring results. The study literature and
report-back method were found to mitigate potential negative impacts.
Conclusion: Biomonitoring study design, including clear communication about the benefits of
breastfeeding and the manner in which individual results are distributed, can prevent negative
impacts of biomonitoring on breastfeeding. Adoption of more specific standards for biomonitoring
studies and continued study of risk communication issues related to biomonitoring will help protect
participants from harm.
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Background
Biomonitoring, or the measure of chemicals that have
accumulated in the body ("body burden"), has long been
used to monitor individual and population-wide expo-
sures to chemicals such as lead and mercury [1,2]. Epide-
miologists and exposure assessors trying to understand
exposure pathways between the environment and the
individual, as well as advocacy groups drawing attention
to the ubiquitous nature of environmental contaminants,
have used biomonitoring as an effective tool [2,3].
Public interest in biomonitoring has increased; technol-
ogy to measure chemicals in various media has also
improved, resulting in more biomonitoring studies, iden-
tifying a wider range of chemicals in people. The ability to
conduct biomonitoring has outpaced our knowledge
about the ethics of biomonitoring [1]. As with any human
subjects research, biomonitoring involves a number of
ethical issues. Participants are often told that they have
been exposed to and have a body burden of a chemical
about which little is known. The risk to participants is
therefore more of a psychological burden than the risk of
physical harm. Examples of potential harm include the
knowledge that exposure has taken place, the fear of a neg-
ative health outcome, and concern that chemicals may be
passed to offspring. Another potential negative impact
specific to breastmilk biomonitoring is the concern that
participants will limit breastfeeding because of fears about
the effect of toxins in breastmilk on infants [1].
Impacts of Biomonitoring on Breastfeeding
There is significant evidence of the benefits of breastfeed-
ing for the long- and short-term health of a child [4].
Accordingly, the American Academy of Pediatrics recom-
mends that breastfeeding continue for the first year of life.
There is very little published on the impact that learning
about contaminants in breastmilk has on the decision to
breastfeed. One study conducted following an industrial
accident in Michigan examined the psychological effects
of the subsequent contamination on nursing mothers in
the community [5]. The 1973 incident involved the acci-
dental introduction of polybrominated biphenyl (PBB)
into animal feed which resulted in contamination of meat
and dairy products which were subsequently distributed
for human consumption [6]. Hatcher [5] interviewed 97
women who had obtained PBB analysis of their breast-
milk. Fifteen percent chose to stop breastfeeding after
receiving analytical results. A second study investigating
exposures from the same accident measured the preva-
lence and duration of breastfeeding among 466 women
exposed to PBB [7]. Women with high PBB levels were
found to be no less likely to breastfeed than women with
moderate or low levels. Duration of breastfeeding was not
associated with PBB serum concentration, indicating that
PBB did not negatively impact the ability to breastfeed.
When asked why they chose to stop or limit breastfeeding,
none of the women in the study cited concerns about PBB
contamination [7].
More recently, there has been anecdotal evidence from
lactation consultants that nursing mothers' concerns
about contaminants in breastmilk increase after results of
biomonitoring studies are publicized [8,9]. The National
Research Council (NRC) Committee on Human Biomon-
itoring for Environmental Toxicants report, "Human Bio-
monitoring for Environmental Chemicals,"
acknowledged the potential for poorly designed breast-
milk biomonitoring studies to negatively impact breast-
feeding rates, yet asserted that studies should be
conducted because of the importance of the data for
efforts to reduce chemical body burdens [1].
Communication of Biomonitoring Results
There is much debate about the issue of whether and how
to provide individual results to the participants of
research studies. The traditional clinical model does not
include distribution of results unless they are clinically
relevant [10,11]. However, many researchers support giv-
ing participants personal biomonitoring results, citing
principles of respect and autonomy [10-12]. An expert
panel convened to consider issues related to breastmilk
biomonitoring affirmed that participants should have the
option of obtaining individual results [13]. The NRC
agrees that participants should have access to individual
results, even if there is great uncertainty about the signifi-
cance [1], and a lay panel convened at the Boston Consen-
sus Conference on Biomonitoring felt similarly [14].
Assessing the Impact of Breastmilk Biomonitoring Studies 
on Participants
Several expert panels have been convened to consider
questions related to biomonitoring and to address issues
such as participant recruitment and sampling, analytical
issues, and methods for conducting studies without nega-
tively impacting breastfeeding rates. [1,15-17].
Although the recommendations of the technical panels
have been based on the collective experiences of research-
ers and experts, there has been little published on the per-
ceptions of participants of biomonitoring studies to
corroborate expert recommendations. Accordingly, we
conducted the present study as a follow-up to the Greater
Boston PBDE (GB-PBDE) biomonitoring study to better
understand the impact of biomonitoring studies on
breastfeeding women. The GB-PBDE biomonitoring study
measured polybrominated diphenyl ethers (PBDEs) in
the breastmilk of first-time mothers [18]. PBDEs are a
group of chemicals used as flame retardants in many
household products including electronics and furniture.
Results of animal studies suggest reproductive and devel-Environmental Health 2009, 8:4 http://www.ehjournal.net/content/8/1/4
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opmental effects, neurotoxicity, and endocrine disruption
[19-21].
The primary objective of the follow-up study was to eval-
uate the impact of participating in a breastmilk biomoni-
toring study on breastfeeding practices; this included an
assessment of how recruitment materials and other study
literature were perceived by participants, whether or not
participants wanted to obtain individual results, an evalu-
ation of the manner in which results were communicated
to participants, and determining if obtaining individual
body burden results impacted attitudes towards breast-
feeding.
Methods
Overview of the GB-PBDE Study
The Greater Boston PBDE (GB-PBDE) Body Burden
Project was conducted during 2003–2005 [18]. The bio-
monitoring study was approved by the Boston University
Medical Center Institutional Review Board (IRB) as was
the subsequent follow-up study. Methodology for the GB-
PBDE study has been published in detail elsewhere [18].
Recruitment was conducted at three different sites within
the Greater Boston area including a health center in one
ethnically diverse community (Lowell) and two private
obstetrics/maternity centers in predominantly white,
highly educated communities (Cambridge, Brookline).
Biomonitoring participants were recruited in the late
stages of pregnancy through the first post-partum weeks.
Women who were eligible to participate in the study were
given information on PBDEs and biomonitoring, infor-
mation on the benefits of breastfeeding, and an informed
consent form. Once consent was obtained, participants
were asked a series of questions about general health, die-
tary and consumer habits, and household goods. Partici-
pants provided breastmilk samples two to eight weeks
after giving birth, and a subset of participants provided a
sample of household dust. Forty-six women participated
in the study. Participant characteristics are summarized in
Table 1.
The GB-PBDE study was designed to follow many of the
recommendations set forth in the guidelines issued fol-
lowing the 2002 Technical Workshop on Human Milk
Surveillance and Research on Environmental Chemicals
in the United States: the need to recommend and support
breastfeeding [15]; the importance of a thorough
informed consent process; and the need to share results
with participants [13]. The protocol was consistent with
many of the recommendations issued at a subsequent
Technical Workshop in 2005, such as 1) include protocols
and information that emphasize that breastfeeding is the
best infant nutrition; 2) include lactation consultants on
study staff; 3) provide clearly written and non-alarming
fact sheets; and 4) emphasize to participants that breast-
feeding has been found to be beneficial for the long-term
overall health of children even though environmental
chemicals have historically been present in human milk
[22]. Accordingly, while recruitment information clearly
described the issue of bioaccumulation and concerns
about PBDEs, communication with participants through-
out the GB-PBDE study emphasized the benefits of breast-
feeding, and study literature included a "breastfeeding is
best" logo wherever possible. Recruitment materials
included fact sheets on the health benefits of breastfeed-
ing [23], contact information for breastfeeding resources,
and information specifically addressing the issue of con-
taminants in breastmilk [24] (see Additional Files 1, 2, 3
for examples of materials distributed during participant
recruitment). A lactation consultant was on-site for all
recruitment efforts in Lowell and available by phone to all
potential participants. A Community Advisory Board,
including lactation consultants, environmental health
educators, and community health workers reviewed all
documents for content and readability.
Although the IRB initially objected to distribution of indi-
vidual results, citing potential harm to participants,
project staff felt that results could be made available in a
way that provided support to participants and mitigated
the risk of harm. Once individual biomonitoring data
were available, a letter was sent inviting participants to
call and speak to either the study coordinator or to a phy-
sician on our study team to obtain individual results.
Alternatively, biomonitoring participants could attend a
forum, open only to participants and their partners, at
which results were communicated privately. The protocol
was designed to fulfill participants' right to receive results,
while not mandating that participants obtain individual
data. Results were not mailed to participants because we
felt that participants should have the opportunity to ask
questions about the study immediately after receiving
results.
Individual results were presented to participants in the
context of the overall study, comparing individual results
with average concentrations as well as the range. Partici-
pants were told that the study found PBDE body burden
to be associated with consumption of dairy fat and meat
as well as concentrations of PBDE in house dust, but that
the study did not provide sufficient evidence to support
specific recommendations to reduce body burden. Body
burden concentrations were also compared to the concen-
trations given to animals in laboratory tests, and results of
laboratory studies were discussed. However, participants
were advised that human health implications for PBDE
body burden were still unclear.Environmental Health 2009, 8:4 http://www.ehjournal.net/content/8/1/4
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Overview of the Follow-up Study
The follow-up study was conducted two months after bio-
monitoring results were made available, five to 17 months
after biomonitoring participants had been initially
recruited into the GB-PBDE study. Attempts were made to
contact all 46 biomonitoring participants. The brief tele-
phone questionnaire included fifteen questions covering
several broad categories: the impact of learning about bio-
monitoring and PBDEs on attitudes towards breastfeed-
ing; whether participants wanted to obtain individual
body burden data; the impact of individual results on atti-
tudes towards breastfeeding; and changes in environmen-
tal health awareness (see Additional File 4 for the follow-
up questionnaire). Closed-ended questions were supple-
mented with open-ended follow-up questions and probes
to more fully capture participants' attitudes and opinions
regarding study design and communication of results.
Data Analysis
Results of the follow-up questionnaire were transcribed
by the interviewer. Responses to closed questions (often a
yes/no answer) were summarized and analyzed quantita-
tively. Responses to open-ended probes were analyzed
using coding techniques commonly utilized for qualita-
tive research methods [25]. Participants' responses were
examined, and recurrent themes in the responses were
used to set up a framework through which to analyze
results. This was an iterative method for which responses
were reviewed for the development of codes and then re-
read for the refinement and organization of the codes.
Responses were first organized into broad categories, such
as "no impact on breastfeeding duration" which closely
followed the theme of the questionnaire. Codes within
this category, such as "impacts of study literature" or
"potential for impact with different results" were then
Table 1: Participant characteristics for the GB-PBDE project and follow-up study
GB-PBDE Project Follow-Up Study
Lowell Cambridge/Brookline Total Participants Did Not Respond Lost to Follow Up
N 54 1 4 6 3 1 8 7
Age of Mother (years)
Average 21.0 33.6 32.2 33.5 31.0 27.7
Range 19–23 28–41 19–41 28–41 21–39 19–36
Age of Baby at time of follow-up study 
(months)
Average 11.3 12.3 12.4
Range (5.8–15) (9–15) (10–17)
Smoking Status
Current smoker 40% 2.4% 6.5% 3% 0% 29%
Former smoker 0% 12.2% 10.9% 12.9% 12.5% 0%
Never smoker 60% 85.4% 82.6% 84.1% 87.5% 71%
Highest Education Level Achieved
HS graduate 40% 0% 6.5% 0% 12.5% 29%
Some college 60% 0% 4.3% 0% 12.5% 14%
College grad 0% 100% 89% 100% 75% 57.1%
Race/Ethnicity
White 40% 93% 87% 97% 63% 86%
Asian 60% 0% 7% 0% 25% 0%
Latina 0% 5% 4% 3% 0% 14%
Af. American 0% 2% 2% 0% 13% 0%
At time of GB-PBDE Recruitment:
Already breastfeeding 63% 71%
Planning to breastfeed 37%a 23%
Very likely/considering breastfeeding 6%
a The follow-up questionnaire asked participants who were not already breastfeeding at the time they enrolled in the biomonitoring study to 
describe whether they were "planning to breastfeed", "very likely to breastfeed", or "considering breastfeeding." The original GB-PBDE 
questionnaire did not make this distinction; biomonitoring participants were described as either currently breastfeeding or planning to breastfeed.Environmental Health 2009, 8:4 http://www.ehjournal.net/content/8/1/4
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devised based on the recurring themes in participants'
responses.
Results
Of the 46 participants of the GB-PBDE study, 31 (67%)
were reached and agreed to participate in the follow-up
study. Eight were left messages but did not call back; seven
were lost to follow up. We were not able to reach any of
the biomonitoring participants from Lowell (n = 5). As a
result, non-participants and participants differed with
regard to race and education. The majority of follow-up
study participants were white and highly educated. Over-
all there appeared to be little difference between partici-
pants and non-participants with regard to maternal or
baby age at the time of follow-up.
Of the 31 participants of the follow-up study, 22 (71%)
had just given birth and had already initiated breastfeed-
ing at the time they were recruited for the biomonitoring
study. Nine (29%) were still pregnant at the time of initial
recruitment; of these, seven (23%) were "definitely plan-
ning" to breastfeed while two (6%) were "very likely" or
"considering" breastfeeding at that time. This is represent-
ative of the overall GB-PBDE study population; most par-
ticipants were committed to or already breastfeeding at
the time that they were recruited. Characteristics of partic-
ipants and non-participants of the follow-up study are
summarized in Table 1.
Impacts on Attitudes towards Breastfeeding
Women were asked, "Did the information given to you
about the study change how you felt about breastfeed-
ing?" None of the 31 women reported having changed her
plans to breastfeed because of the general information on
biomonitoring or PBDEs, but four women reported that
the study information made them think differently about
breastfeeding. One woman responded:
It made me think that my surroundings were more
toxic than I thought. There's some sorrow in learning
about it, but I don't want to change things without
knowing more. I just do the best I can... eating organic,
breastfeeding.
Of these four women, two specifically identified the
"breastfeeding is best" message that was highlighted
throughout study literature as having a positive effect. As
one woman articulated, "The initial information gave me
a moment of hesitation but the literature was reassuring."
Four other respondents reported that the information
given out reinforced their decision to breastfeed, citing "a
renewed belief" in her decision, "another good reason to
breastfeed" and "validation" of her decision. As one
stated:
I had heard a lot of questions about breastfeeding – if
it's still good to do because of all of the chemicals in
our bodies. I was glad to hear that my opinion was cor-
rect.
Individual Biomonitoring Results
Individual results were made available to participants as
part of the biomonitoring study, two months before the
follow-up questionnaire was conducted. Letters were sent
to all 46 GB-PBDE study participants informing them that
biomonitoring results were available. One letter was
returned as undeliverable. Fourteen of the participants
(30%) called or attended the forum to obtain individual
results; all 14 of these women also participated in the fol-
low-up study. Once contacted for the follow-up study, an
additional 16 participants (34%) who had not called to
obtain results stated that they wanted individual results.
Four commented that the method for distributing results
was inconvenient, and that sending results via e-mail or a
letter would have been preferable. Of the 31 people who
participated in the follow up questionnaire, only one
declined to receive individual results, noting, "I'm a little
scared to see it... There isn't anything I can do to change
things, so I'd rather not know."
The sixteen women who wanted individual data but had
not called in prior to the follow-up study were given their
results after they had finished the follow-up question-
naire. Their responses to the follow-up questionnaire were
therefore not affected by individual results, and they are
not included in the following section.
Of the 14 individuals who called or attended meetings to
obtain results, five had stopped breastfeeding before
results were made available, so individual results could
not have affected the duration of breastfeeding. The
women who were still breastfeeding when results were
made available were asked, "Did learning about the PBDE
levels in your milk affect how long you breastfed your
baby?" Of the women who were still breastfeeding when
results were made available, all nine continued to breast-
feed at least until the time of the follow-up questionnaire.
All reported that the results had not changed the duration
that they planned to breastfeed. However, comments in
response to follow-up probes suggested that there was
potential for individual body burden information to
affect their attitudes. For example, one participant noted,
"If I had gotten very high results within a short time of
testing, it might have affected me."
Two of the participants with results at the higher end of
the range expressed concern about the potential for
impacts on her baby's health. Both cited study literature
and the "breastfeeding is best" message as factors in herEnvironmental Health 2009, 8:4 http://www.ehjournal.net/content/8/1/4
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comfort with breastfeeding as well as the availability of
study staff to discuss results. One woman stated:
Learning about my own results made me nervous...
made my husband nervous, but I continued because
of the message that breastfeeding is best.
The other noted that the manner in which results were dis-
tributed helped her understand and feel comfortable with
the results. She responded:
.... I was very affected by how the results were framed
– talking about it in terms of averages, relations to ani-
mal studies, and the message that breastfeeding is
best....
In addition, there were five participants who expressed
relief that their results were in the lower end of the range,
as one noted:
[low results] ... validated my decision to breast-
feed...although with high results maybe I would have
talked to my doctor about breastfeeding.
These responses demonstrate that there is potential for
individual body burden results to create anxiety, and that
the manner in which results are distributed must be con-
sidered as an important part of study design.
To gauge the effect that the overall study experience had
had on decisions regarding breastfeeding, we asked all
thirty-one participants of the follow-up study if they
would breastfeed a second child if they had one. Thirty
(97%) answered that they would breastfeed again; only
one participant said that her decision would depend on
her individual body burden results, but that she most
likely would breastfeed again.
Methodology for Distributing Results
One of the study questions focused on means by which
individual results were distributed. While 30 (97%) of the
follow-up study participants expressed an interest in per-
sonal results, only 14 (47%) called or attended meetings
to obtain them. One of the barriers to accessing individual
results was the requirement to call or attend a meeting.
Many participants of the follow-up study mentioned how
busy they were; six reported that they lost the first letter or
forgot to call for results. While four participants of the fol-
low-up study reported that they would have preferred to
have results sent to them, two others stated that the man-
ner in which results were distributed facilitated their
understanding of the results and mitigated concerns.
Impacts on Lifestyle
Recruiting materials and topics covered in the exposure
questionnaire may have raised participant awareness
about how household products and personal choices
might affect one's health. We asked participants about
changes they had made to their lifestyle because of the
study. Fifteen participants (48%) felt that the study had
no impact on their lifestyle or attitude. Eleven (35%)
reported changes to the way they thought about their
environment. Some of the responses demonstrated a
heightened awareness of potential PBDE exposure within
the home: "I thought about the foam things that I could
do without," "Our couch got ripped, and I thought about
PBDE...," "I became more aware of dairy products and
consumption..."
Five participants (16%) cited tangible changes they had
made to their lifestyle because of the study. Some
attempted to reduce exposure to PBDE-treated products.
For example, one participant reported, "we're being better
about dust in the house." Other participants made
changes that were related to overall health including
choosing to eat more organic products and reducing sun
exposure.
The biomonitoring study provided an opportunity for
participants to learn about environmental health. This
was seen as one of the benefits of the study by several par-
ticipants, as articulated by one woman:
I found that there is a real lack of understanding about
breastfeeding... it was hard to find information on
how the mom's health and environment affects breast-
milk.
Discussion
Attitudes Towards Breastfeeding
Overall, the findings of the follow-up questionnaire sug-
gested that participation in the biomonitoring study,
including reading recruitment materials, providing a
breastmilk sample, and learning about individual body
burden, did not negatively impact participants' attitudes
towards breastfeeding or the duration of breastfeeding.
However, some participants' responses suggested that
there is potential for biomonitoring studies to raise con-
cern about breastfeeding, and that aspects of our study
design were able to mitigate negative impacts. Participants
specifically mentioned the "breastfeeding is best" logo,
the context in which results were provided, and the man-
ner in which results were personally communicated. Our
findings support the recommendations of the Technical
Workshop outlined above in that breastfeeding support
and clearly written, non-alarmist information appear to
have mitigated potential negative impacts of the study.
Future evaluation of biomonitoring participant experi-Environmental Health 2009, 8:4 http://www.ehjournal.net/content/8/1/4
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ences should focus on the details of study design more
closely.
While the follow-up questionnaire focused on potential
negative impacts, many participants considered their
experience in the study to have had a positive impact, val-
idating their decisions to breastfeed. Several of our partic-
ipants had seen media coverage of previous
biomonitoring studies and had concerns about the effect
of bioaccumulation on breastmilk and infant health. Par-
ticipants described our information as reassuring, inform-
ative, and accessible.
There was particular concern about participants from
Lowell because the population historically has low breast-
feeding rates. The experiences of this population could
not be directly assessed due to lack of participation in the
follow-up study; however, the director of the Lowell
health center believed that the study had a positive impact
by providing lactation information and support to
patients and focusing staff attention on the need for more
lactation education. Because of the differences between
the Lowell group and other biomonitoring participants, it
cannot be assumed that the findings of the follow-up
study can be applied to participants from the Lowell
group. Attitudes towards breastfeeding differ by class,
race, and culture. It is important to assess the experiences
of participants from different backgrounds in order to
more fully understand the potential for impacts on differ-
ent communities, particularly communities that are
already affected by low breastfeeding rates.
It is difficult to compare the results of our follow-up study
to the findings of the studies conducted following the
Michigan PBB event. Hatcher [5] demonstrated the poten-
tial for individual biomonitoring information to nega-
tively impact breastfeeding, but participants from the
Hatcher study were recruited from a group of women who
were sufficiently concerned about contamination to sub-
mit breastmilk for analysis. That study was also conducted
shortly after the massive contamination episode, and was
likely affected by the crisis atmosphere surrounding the
event. Thomas participants were drawn from the general
exposed population, and included women who gave birth
up to twenty-five years following the accident. PBB was
measured in blood, not breastmilk [7].
Impacts of Individual Results on Breastfeeding
Many of the GB-PBDE participants who called to obtain
results had questions about the interpretation of results
and the potential for health impacts; however, all of the
women who were breastfeeding at the time biomonitor-
ing results were made available were still breastfeeding at
the time of the follow-up study. All nine stated that the
individual body burden results had not affected their deci-
sion about breastfeeding duration.
The potential for our study to impact breastfeeding dura-
tion may have been limited by the amount of time it took
to collect samples and conduct analysis. Results were not
available to participants until more than one year after the
study was initiated, three to 15 months (average of nine
months) after women had been recruited and breastfeed-
ing had been initiated. Studies of breastfeeding practices
have found that breastfeeding most often stops after 2–3
months [26]. The women who were still breastfeeding at
the time our results were made available were already
beyond the first months of breastfeeding and may have
been more likely to continue breastfeeding regardless of
body burden results. Providing individual results to
women in their initial months of breastfeeding could
potentially result in a greater negative impact on breast-
feeding duration.
The time lag between sample collection and distribution
of results may have affected how participants were
impacted. The time-line of a study, including when
report-back will be conducted, is an important considera-
tion for study design, and is an example of the need for a
standardized biomonitoring protocol.
Distribution of Results
The GB-PBDE protocol allowed participants to choose
whether they wanted to obtain individual results. We
required that participants talk to study staff to obtain
results. This procedure worked well for participants who
had questions or concerns and appreciated immediate
access to study staff. However, it reduced the number of
participants who obtained results. Design of report-back
protocol should consider both the effort required of par-
ticipants to obtain results and the need to respond to par-
ticipants' questions and concerns. This is difficult because
the needs of individual participants vary widely. Not only
is there a wide range in individual body burden results,
but individuals also differ with respect to risk perception
and risk tolerance [1]. Continued evaluation of result
communication must be included in future biomonitor-
ing studies in order to better understand the issue.
Distribution of individual results, particularly if con-
ducted on an individual basis with counseling, has impli-
cations for research budgets. However, the cost
considerations of providing individual results are out-
weighed by the need to treat participants with respect
[11]. Standardization of biomonitoring report-back pro-
tocol which includes the need to distribute results on an
individual basis will help researchers justify study time-
lines and budgets to IRB reviewers and funding agencies.Environmental Health 2009, 8:4 http://www.ehjournal.net/content/8/1/4
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Lifestyle and Attitudes
The GB-PBDE study was an opportunity to distribute
information about biomonitoring and counterbalance
misleading headlines about breastmilk. It was also an
opportunity to raise awareness about chemicals in our
everyday environment. The responses to questions about
lifestyle and attitude changes demonstrated that the par-
ticipants of the biomonitoring study were more aware of
chemicals in consumer products as a result of the study.
Study Limitations
There were several study design issues which may have
affected the outcome of the follow-up study.
Participants may have been influenced by the fact that the
study coordinator was a nursing mother. Perceived simi-
larity between interviewers and subjects has been found to
influence survey responses [27,28]. In both the biomoni-
toring and the follow-up study, participants may have
been more willing to answer questions openly. The inter-
viewer's status as a nursing mother may also have reduced
concerns about breastfeeding or deterred participants
from making negative statements about breastfeeding.
Results of the follow-up study may not be generalizable to
more diverse populations. None of the biomonitoring
participants from Lowell (n = 5) participated in the fol-
low-up study. We do not have data on women who were
eligible to participate but did not enroll. Nor do we have
data on women who ultimately did not choose to breast-
feed, including, perhaps, women who were negatively
affected by the study recruitment literature. The study also
does not address the potential impact of biomonitoring
results on the general public, including women who
might consider breastfeeding in the future.
Participants were contacted for the follow-up study at a
time when their babies were between the ages of 4–18
months. Many of the participants were juggling the
demands of motherhood and work; many mentioned
how busy they were. Women were often rushed on the
phone or interrupted by a crying baby, and the richness of
the data was affected by the brevity of the interviews.
Many of the women who did not initially call in to receive
results mentioned time constraints or lack of organization
as the reason they did not contact us. Participation in the
follow-up study may have been similarly affected.
Conclusion
The comments from our participants provided insight
into the ways that participation in a breastmilk biomoni-
toring study can affect participants' attitudes towards
breastfeeding. They also show that study design, including
study literature and the method for report-back, can miti-
gate negative impacts. Standardization of biomonitoring
studies is needed to fully protect participants' rights. The
development of appropriate ethical standards requires
input from many different sectors including researchers
from varied disciplines such as risk communication,
bioethics, and epidemiology; community groups and the
lay public; clinicians and lactation consultants; and mem-
bers of Institutional Review Boards. As the technology of
biomonitoring advances, the discussion of the bioethics
of biomonitoring must keep pace so that the Human Sub-
ject Research standards of respect for persons, benefi-
cence, and justice can be upheld.
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